Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity
ABSTRACT Efficient vaccination against infectious agents and tumors depends on specific antigen targeting to dendritic cells (DCs). We report here that biosafe coronavirus-based vaccine vectors facilitate delivery of multiple antigens and immunostimulatory cytokines to professional antigen-presentin...
Guardado en:
Autores principales: | Luisa Cervantes-Barragan, Roland Züst, Reinhard Maier, Sophie Sierro, Jozef Janda, Frederic Levy, Daniel Speiser, Pedro Romero, Pierre-Simon Rohrlich, Burkhard Ludewig, Volker Thiel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e25819499c9c49ca9527573fd48a887c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections.
por: Gennady Bocharov, et al.
Publicado: (2010) -
NIR-guided dendritic nanoplatform for improving antitumor efficacy by combining chemo-phototherapy
por: Ge R, et al.
Publicado: (2019) -
Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses
por: Lauren D. Aarreberg, et al.
Publicado: (2018) -
Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment
por: Glauco Akelinghton Freire Vitiello, et al.
Publicado: (2021) -
Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
por: Laurence Josset, et al.
Publicado: (2013)